CLX

CLX
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $1.429B ▼ | $471M ▼ | $80M ▼ | 5.598% ▼ | $0.65 ▼ | $189M ▼ |
| Q4-2025 | $1.988B ▲ | $499M ▼ | $332M ▲ | 16.7% ▲ | $2.7 ▲ | $492M ▲ |
| Q3-2025 | $1.668B ▼ | $501M ▼ | $186M ▼ | 11.151% ▼ | $1.51 ▼ | $336M ▲ |
| Q2-2025 | $1.686B ▼ | $502M ▼ | $193M ▲ | 11.447% ▲ | $1.56 ▲ | $315M ▲ |
| Q1-2025 | $1.762B | $513M | $99M | 5.619% | $0.8 | $255M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $166M ▼ | $5.528B ▼ | $5.39B ▲ | $-22M ▼ |
| Q4-2025 | $167M ▼ | $5.561B ▲ | $5.079B ▼ | $321M ▲ |
| Q3-2025 | $226M ▼ | $5.512B ▼ | $5.322B ▼ | $27M ▲ |
| Q2-2025 | $290M ▲ | $5.577B ▲ | $5.456B ▲ | $-41M ▼ |
| Q1-2025 | $278M | $5.497B | $5.273B | $60M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $82M ▼ | $93M ▼ | $-34M ▲ | $-59M ▲ | $-1M ▲ | $57M ▼ |
| Q4-2025 | $336M ▲ | $294M ▲ | $-76M ▼ | $-279M ▲ | $-59M ▲ | $219M ▼ |
| Q3-2025 | $191M ▼ | $286M ▲ | $-53M ▲ | $-299M ▼ | $-65M ▼ | $233M ▲ |
| Q2-2025 | $194M ▲ | $180M ▼ | $-54M ▼ | $-109M ▲ | $12M ▼ | $127M ▼ |
| Q1-2025 | $103M | $221M | $89M | $-237M | $75M | $182M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Health and Wellness | $630.00M ▲ | $630.00M ▲ | $740.00M ▲ | $560.00M ▼ |
Household | $450.00M ▲ | $470.00M ▲ | $640.00M ▲ | $360.00M ▼ |
International | $270.00M ▲ | $260.00M ▼ | $270.00M ▲ | $250.00M ▼ |
Lifestyle | $340.00M ▲ | $310.00M ▼ | $340.00M ▲ | $240.00M ▼ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Clorox today looks like a stable, mature consumer business that has navigated a period of margin pressure and emerged with healthier profitability and cash flow, even though top-line growth has been subdued. Its balance sheet carries meaningful leverage and only modest cash, which is mitigated but not eliminated by strong recurring cash generation. The company’s enduring strengths lie in its trusted brands, leading market positions, pricing power, and broad distribution, all reinforced by a growing capability in data-driven innovation and sustainability-focused products. Key things to monitor over time are its ability to keep margins firm in a competitive, inflation-prone environment, the pace of balance sheet strengthening, and how well its digital and ESG-oriented strategies translate into durable consumer demand and brand relevance.
NEWS
November 20, 2025 · 6:45 AM UTC
Clorox to Present at Morgan Stanley Global Consumer & Retail Conference
Read more
November 18, 2025 · 6:20 PM UTC
Clorox Declares Regular Quarterly Dividend of $1.24 Per Share
Read more
November 12, 2025 · 9:03 AM UTC
Clorox Launches Free Holiday Gift of Clean: Complimentary In-Home Cleaning Service and Essential Product Bundle for Shoppers
Read more
November 5, 2025 · 9:14 AM UTC
HIDDEN VALLEY RANCH® TURNS TINY NYC APARTMENT INTO THE ULTIMATE POP-UP RESTAURANT EXPERIENCE
Read more
November 3, 2025 · 4:10 PM UTC
Clorox Reports Q1 Fiscal Year 2026 Results, Updates Outlook
Read more
About The Clorox Company
https://www.thecloroxcompany.comThe Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $1.429B ▼ | $471M ▼ | $80M ▼ | 5.598% ▼ | $0.65 ▼ | $189M ▼ |
| Q4-2025 | $1.988B ▲ | $499M ▼ | $332M ▲ | 16.7% ▲ | $2.7 ▲ | $492M ▲ |
| Q3-2025 | $1.668B ▼ | $501M ▼ | $186M ▼ | 11.151% ▼ | $1.51 ▼ | $336M ▲ |
| Q2-2025 | $1.686B ▼ | $502M ▼ | $193M ▲ | 11.447% ▲ | $1.56 ▲ | $315M ▲ |
| Q1-2025 | $1.762B | $513M | $99M | 5.619% | $0.8 | $255M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $166M ▼ | $5.528B ▼ | $5.39B ▲ | $-22M ▼ |
| Q4-2025 | $167M ▼ | $5.561B ▲ | $5.079B ▼ | $321M ▲ |
| Q3-2025 | $226M ▼ | $5.512B ▼ | $5.322B ▼ | $27M ▲ |
| Q2-2025 | $290M ▲ | $5.577B ▲ | $5.456B ▲ | $-41M ▼ |
| Q1-2025 | $278M | $5.497B | $5.273B | $60M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $82M ▼ | $93M ▼ | $-34M ▲ | $-59M ▲ | $-1M ▲ | $57M ▼ |
| Q4-2025 | $336M ▲ | $294M ▲ | $-76M ▼ | $-279M ▲ | $-59M ▲ | $219M ▼ |
| Q3-2025 | $191M ▼ | $286M ▲ | $-53M ▲ | $-299M ▼ | $-65M ▼ | $233M ▲ |
| Q2-2025 | $194M ▲ | $180M ▼ | $-54M ▼ | $-109M ▲ | $12M ▼ | $127M ▼ |
| Q1-2025 | $103M | $221M | $89M | $-237M | $75M | $182M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Health and Wellness | $630.00M ▲ | $630.00M ▲ | $740.00M ▲ | $560.00M ▼ |
Household | $450.00M ▲ | $470.00M ▲ | $640.00M ▲ | $360.00M ▼ |
International | $270.00M ▲ | $260.00M ▼ | $270.00M ▲ | $250.00M ▼ |
Lifestyle | $340.00M ▲ | $310.00M ▼ | $340.00M ▲ | $240.00M ▼ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Clorox today looks like a stable, mature consumer business that has navigated a period of margin pressure and emerged with healthier profitability and cash flow, even though top-line growth has been subdued. Its balance sheet carries meaningful leverage and only modest cash, which is mitigated but not eliminated by strong recurring cash generation. The company’s enduring strengths lie in its trusted brands, leading market positions, pricing power, and broad distribution, all reinforced by a growing capability in data-driven innovation and sustainability-focused products. Key things to monitor over time are its ability to keep margins firm in a competitive, inflation-prone environment, the pace of balance sheet strengthening, and how well its digital and ESG-oriented strategies translate into durable consumer demand and brand relevance.
NEWS
November 20, 2025 · 6:45 AM UTC
Clorox to Present at Morgan Stanley Global Consumer & Retail Conference
Read more
November 18, 2025 · 6:20 PM UTC
Clorox Declares Regular Quarterly Dividend of $1.24 Per Share
Read more
November 12, 2025 · 9:03 AM UTC
Clorox Launches Free Holiday Gift of Clean: Complimentary In-Home Cleaning Service and Essential Product Bundle for Shoppers
Read more
November 5, 2025 · 9:14 AM UTC
HIDDEN VALLEY RANCH® TURNS TINY NYC APARTMENT INTO THE ULTIMATE POP-UP RESTAURANT EXPERIENCE
Read more
November 3, 2025 · 4:10 PM UTC
Clorox Reports Q1 Fiscal Year 2026 Results, Updates Outlook
Read more

CEO
Linda J. Rendle
Compensation Summary
(Year 2025)

CEO
Linda J. Rendle
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1999-08-24 | Forward | 2:1 |
| 1997-09-03 | Forward | 2:1 |
| 1987-06-02 | Forward | 2:1 |
Ratings Snapshot
Rating : B
Most Recent Analyst Grades

Jefferies
Buy

Wells Fargo
Equal Weight

Morgan Stanley
Equal Weight

RBC Capital
Sector Perform

JP Morgan
Neutral

Citigroup
Neutral

UBS
Neutral

B of A Securities
Neutral

DA Davidson
Neutral

Barclays
Underweight
Grade Summary
Price Target
Institutional Ownership

METATRON CAPITAL SICAV PLC
123.058M Shares
$13.283B

VANGUARD GROUP INC
15.739M Shares
$1.699B

BLACKROCK INC.
10.908M Shares
$1.177B

BLACKROCK, INC.
10.383M Shares
$1.121B

ICAHN CAPITAL LP
10M Shares
$1.079B

STATE STREET CORP
8.434M Shares
$910.396M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
4.151M Shares
$448.094M

INVESCO LTD.
3.996M Shares
$431.284M

BLACKROCK FUND ADVISORS
3.305M Shares
$356.735M

MORGAN STANLEY
3.196M Shares
$344.956M

GEODE CAPITAL MANAGEMENT, LLC
3.162M Shares
$341.325M

STIFEL FINANCIAL CORP
3.037M Shares
$327.835M

VAN ECK ASSOCIATES CORP
2.71M Shares
$292.514M

TWO SIGMA ADVISERS, LP
2.035M Shares
$219.615M

ROYAL BANK OF CANADA
1.796M Shares
$193.91M

TWO SIGMA INVESTMENTS, LP
1.74M Shares
$187.834M

VALUEINVEST ASSET MANAGEMENT S.A.
1.643M Shares
$177.324M

NORGES BANK
1.586M Shares
$171.191M

NORTHERN TRUST CORP
1.539M Shares
$166.12M

ANALYTIC INVESTORS, LLC
1.532M Shares
$165.416M
Summary
Only Showing The Top 20



